An update on hip fracture risk associated with anticoagulant therapy: warfarin versus direct oral anticoagulants
- PMID: 32795203
- DOI: 10.1080/14740338.2020.1811230
An update on hip fracture risk associated with anticoagulant therapy: warfarin versus direct oral anticoagulants
Keywords: Apixaban; DOAC; NOAC; betrixaban; bone; dabigatran; edoxaban; fracture; osteocalcin; rivaroxaban; vitamin K; warfarin.
Similar articles
-
Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation.J Am Heart Assoc. 2016 Jun 13;5(6):e003725. doi: 10.1161/JAHA.116.003725. J Am Heart Assoc. 2016. PMID: 27412905 Free PMC article.
-
Risk of Osteoporosis in Patients With Atrial Fibrillation Using Non-Vitamin K Antagonist Oral Anticoagulants or Warfarin.J Am Heart Assoc. 2020 Jan 21;9(2):e013845. doi: 10.1161/JAHA.119.013845. Epub 2020 Jan 10. J Am Heart Assoc. 2020. PMID: 31918601 Free PMC article.
-
Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack.Stroke. 2017 Aug;48(8):2142-2149. doi: 10.1161/STROKEAHA.117.017474. Epub 2017 Jun 27. Stroke. 2017. PMID: 28655814
-
Edoxaban: A direct oral anticoagulant.Am J Health Syst Pharm. 2017 Feb 1;74(3):117-129. doi: 10.2146/ajhp150821. Am J Health Syst Pharm. 2017. PMID: 28122753 Review.
-
Warfarin and Newer Agents: What the Oral Surgeon Needs to Know.Oral Maxillofac Surg Clin North Am. 2016 Nov;28(4):515-521. doi: 10.1016/j.coms.2016.06.011. Epub 2016 Sep 10. Oral Maxillofac Surg Clin North Am. 2016. PMID: 27624772 Review.
Cited by
-
Comparative Risks of Fracture Among Direct Oral Anticoagulants and Warfarin: A Systematic Review and Network Meta-Analysis.Front Cardiovasc Med. 2022 May 23;9:896952. doi: 10.3389/fcvm.2022.896952. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35677694 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical